Walleye Trading
PRCT icon

Walleye Trading’s Procept Biorobotics PRCT Stock Holding History

Walleye Trading’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
11,000
+10,200
+1,275% +$255K ﹤0.01% 3024
2026
Q1 		$20K Sell
800
-2,900
-78% -$81.7K ﹤0.01% 3863
2025
Q4 		$116K Buy
3,700
+600
+19% +$19.9K ﹤0.01% 3668
2025
Q3 		$111K Buy
3,100
+1,900
+158% +$86.8K ﹤0.01% 3668
2025
Q2 		$69.1K Sell
1,200
-2,900
-71% -$164K ﹤0.01% 3731
2025
Q1 		$239K Buy
+4,100
New +$280K ﹤0.01% 2981

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Walleye Trading's PRCT Position: Q2 2026 in Review

Walleye Trading sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 2,050 shares — an estimated $51.3K sold.

Walleye Trading first reported a position in PRCT in Q2 2025 and held it in 4 quarters. The position peaked at $162K in Q4 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Walleye Trading reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 2,050 Procept Biorobotics shares in Q2 2026, an estimated $51.3K.
  • Walleye Trading first reported a position in Procept Biorobotics in Q2 2025 and held it in 4 quarters.
  • Walleye Trading's Procept Biorobotics position peaked at $162K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.